Multiple myeloma research consortium and sunesis pharmaceuticals present data on sns-032 at american association of cancer research annual meeting
April 17th, 2008 by 
admin NORWALK, Conn.–(BUSINESS WIRE)–Apr 16, 2008 - The Multiple
Myeloma Research Consortium (MMRC) in cooperation with Sunesis
Pharmaceuticals presented diagnosing accumulation on the state of
Sunesis’ radiophone wheel inhibitor, SNS-032, in binary myeloma… (Source: Drugs.com - Clinical Trials)
Tags: Annual Meeting, Cancer, Drugs, Research Co
Posted in Cancer | 